Atle Fund Management AB
39 holdingsFiling period: 2026-06-30Current AUM: $370.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 29.8K | $35.8M | $38.1M | 10.31% | -9,901 | 2026-06-30 |
| 2 | MRK | Merck & Co. Inc | 189.4K | $24.3M | $26.6M | 7.19% | +155.5K | 2026-06-30 |
| 3 | JNJ | Johnson & Johnson | 85.4K | $21.7M | $22.7M | 6.15% | -6,952 | 2026-06-30 |
| 4 | ABBV | Abbvie Inc | 64.3K | $16.2M | $18.4M | 4.98% | -43,856 | 2026-06-30 |
| 5 | CVS | Cvs Health Corp | 146.1K | $15.1M | $13.5M | 3.65% | +122.3K | 2026-06-30 |
| 6 | TMO | Thermo Fisher Scientific Corp | 27.9K | $14.0M | $19.1M | 5.16% | +4.9K | 2026-06-30 |
| 7 | RVMD | Revolution Medicines Inc | 73.1K | $13.7M | $13.4M | 3.63% | -544,168 | 2026-06-30 |
| 8 | BIIB | Biogen Inc | 62.8K | $13.6M | $15.8M | 4.28% | -- | 2026-06-30 |
| 9 | NBIX | Neurocrine Biosciences Inc | 72.9K | $12.3M | $10.6M | 2.87% | -16,787 | 2026-06-30 |
| 10 | MIRM | Mirum Pharmaceuticals Inc | 100.8K | $11.8M | $8.4M | 2.27% | -94,961 | 2026-06-30 |
| 11 | — | Alkermes PLC | 213.3K | $11.2M | $11.2M | 3.02% | -29,144 | 2026-06-30 |
| 12 | IONS | Ionis Pharmaceuticals Inc | 137.1K | $10.9M | $6.0M | 1.61% | +109.3K | 2026-06-30 |
| 13 | ONC | Beone Medicines Ltd-ADR | 35.2K | $10.0M | $13.0M | 3.53% | -6,537 | 2026-06-30 |
| 14 | ISRG | Intuitive Surgical Inc | 24.7K | $9.8M | $11.1M | 3.01% | -46,195 | 2026-06-30 |
| 15 | SYK | Stryker Corporation | 30.3K | $9.5M | $9.3M | 2.51% | +3.4K | 2026-06-30 |
| 16 | VRTX | Vertex Pharmaceuticals Inc | 19.1K | $9.5M | $9.9M | 2.68% | -3,853 | 2026-06-30 |
| 17 | EW | Edwards Lifesciences Corp | 103.2K | $9.3M | $9.3M | 2.53% | -3,288 | 2026-06-30 |
| 18 | BBIO | Bridgebio Pharma Inc | 124.7K | $9.3M | $8.5M | 2.30% | +13.3K | 2026-06-30 |
| 19 | KRYS | Krystal Biotech, Inc | 24.0K | $8.9M | $7.5M | 2.04% | -13,560 | 2026-06-30 |
| 20 | COR | Cencora Inc | 31.1K | $8.8M | $10.3M | 2.78% | +7.7K | 2026-06-30 |
| 21 | — | Newamsterdam Pharma Co NV | 248.8K | $8.4M | $8.4M | 2.28% | +154.1K | 2026-06-30 |
| 22 | ABVX | Abivax SA | 58.2K | $7.8M | $5.0M | 1.36% | +26.6K | 2026-06-30 |
| 23 | INCY | Incyte Corp | 57.0K | $6.5M | $6.5M | 1.74% | +6.2K | 2026-06-30 |
| 24 | IRTC | Irhythm Technologies Inc | 54.1K | $6.4M | $6.6M | 1.78% | +31.8K | 2026-06-30 |
| 25 | BSX | Boston Scientifc | 146.4K | $6.2M | $6.7M | 1.80% | +105.9K | 2026-06-30 |
← Scroll →
Page 1 of 2